tm logo
CREDO
Live/Registered
REGISTERED

on 21 Nov 2023

Last Applicant/ Owned by

Theodor-Fahrner-Straße 6

Pforzheim

DE

75177

Serial Number

97757752 filed on 17th Jan 2023

Registration Number

7224744 registered on 21st Nov 2023

in the Principal Register

Correspondent Address

Peter C. Stomma

Peter C. Stomma

840 N. PLANKINTON AVE

MILWAUKEE, WI 53203

Filing Basis

No Filing Basis

Disclaimer

NO DATA

CREDO

Surgical implants made of artificial materials, namely, medical stents, artificial vascular grafts and blood flow diverters for use in the radiology and neurology sectors, in particular for treating strokes and neurovascular disorders; all the aforesaid goods for use in blood vessels Pharmaceutical preparations for the treatment of strokes and neurovascular disorders

Classification Information


Class [010]
Medical Instrument Products


Surgical implants made of artificial materials, namely, medical stents, artificial vascular grafts and blood flow diverters for use in the radiology and neurology sectors, in particular for treating strokes and neurovascular disorders; all the aforesaid goods for use in blood vessels

Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the treatment of strokes and neurovascular disorders

Mark Details


Serial Number

No 97757752

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 303.238

44D Filed

No

44D Current

No

44E filed

Yes

44E Current

Yes

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
21st Nov 2023REGISTERED-PRINCIPAL REGISTER
21st Nov 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
05th Sep 2023PUBLISHED FOR OPPOSITION
05th Sep 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
16th Aug 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02th Aug 2023ELECTRONIC RECORD REVIEW COMPLETE
28th Jul 2023ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
20th Jul 2023TEAS/EMAIL CORRESPONDENCE ENTERED
20th Jul 2023APPROVED FOR PUB - PRINCIPAL REGISTER
19th Jul 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED